Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Aviragen Therapeutics Inc (NASDAQ:AVIR)

0.6749
Delayed Data
As of Feb 22
 -0.0151 / -2.19%
Today’s Change
0.65
Today|||52-Week Range
2.00
-45.13%
Year-to-Date
No recent news for Aviragen Therapeutics Inc.

Today’s Trading

Previous close0.69
Today’s open0.66
Day’s range0.66 - 0.70
Volume99,660
Average volume (3 months)106,770
Market cap$26.7M
Dividend yield--
Data as of 3:59pm ET, 02/22/2017

Growth & Valuation

Earnings growth (last year)-22.22%
Earnings growth (this year)--
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-62.20%
P/E ratioNM
Price/Sales5.82
Price/Book0.58

Competitors

 Today’s
change
Today’s
% change
ANTHAnthera Pharmaceutic...+0.07+11.14%
NVGNNovogen Ltd+0.13+8.07%
MRNSMarinus Pharmaceutic...-0.10-6.90%
APRIApricus Biosciences ...+0.04+1.29%
Data as of 4:00pm ET, 02/22/2017

Financials

Next reporting dateMay 10, 2017
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$9.3M
Annual profit (last year)-$25.4M
Net profit margin-273.12%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO &
Executive Director
Joseph M. Patti
Chief Financial Officer &
Executive Vice President
Mark P. Colonnese
Corporate headquarters
Alpharetta, Georgia

Forecasts


Search for Jobs